In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Pharmacotherapy in Older People

Online training course by the ESC Working Group on Cardiovascular Pharmacotherapy

25/11/2020 13:00 26/11/2020 16:30 Europe/Paris Pharmacotherapy in Older People

Access event page

ESC Working Group on Cardiovascular Pharmacotherapy DD/MM/YYYY
Pharmacology and Pharmacotherapy


The ESC Working Group on Cardiovascular Pharmacotherapy presents an engaging and interactive course to improve the professional knowledge and skills on cardiovascular pharmacotherapy in older patients.


In Europe and the Western World in particular, the proportion of older people is dramatically increasing, which is predicted to add tremendous extra pressure to the strained healthcare systems.

Cardiovascular drugs are among the most prevalent drugs administered to older people. In particular diuretics, antihypertensives, NOACs, antiarrhythmics, lipid-lowering and glucose-lowering drugs. All these drug classes can lead to increased frailty and should in particular not be prescribed on a one-size-fits-all-basis to older people, and polypharmacy should be countered.

Our goal is for all participants to leave the meeting with the improved competence and confidence to deliver better, personalised therapy to older people, which in turn will have a positive impact on services and patient outcomes.

Conference scientific committee

  • Prof. Juan Tamargo, Spain
  • Prof. Juan Carlos Kaski, UK
What past participants say
  • Over 90% of participants found the course extremely useful and useful to their daily practice
  • More than 80% rated the programme as 'excellent', with the speakers and topics as the most cited best aspects of the event
  • 95% of participants declared that the event fulfilled their educational goals and expected learning outcomes

Preliminary programme

The programme is subject to change.


Ageing and challenges to cardiovascular pharmacotherapy. The added challenge of COVID-19

Drug metabolism in older people


The problem of hypo- and hyperkalemia in older people


How to select anti-hypertensive agents in older patients

Problems with anti-hypertensive therapy in the elderly: case discussion


Therapeutic decisions in the elderly


Lipid-lowering agent selection in the elderly


Tight glycemic control is necessary

Tight glycemic control is not necessary


The use of DOACs in older individuals


Guidelines & effects of the pandemic: cases


Challenges to cardiovascular pharmacotherapy

Challenges to cardiovascular intervention


Problems with polypharmacy in older people


Are we shooting in the dark?

Learning objectives

Reduction of cardiovascular disease burden by pharmacotherapy is a multistep approach, which requires to:

  • identify new potential drugs;
  • test new potential pharmacological compounds in trial setting;
  • get regulatory approval;
  • implement therapies in clinical practice.

Older patients with cardiovascular disease are often found to be undertreated. There are many reasons for this, including polypharmacy, fear of side effects, co-morbidities, frailty and sparse trial evidence of drug efficacy in the elderly. Strategies leading to the rational implementation of pharmacological therapies are therefore necessary in the subgroup of older patients with cardiovascular disease.

The specific aim of the course is to improve the practicing physician’s competence and confidence to deliver better, safer, personalized therapy for older people, which should, in turn,  have a positive impact on patient outcomes and quality of life.


Registration closed. 

For any questions, please contact us at

The Pharmacotherapy in Older People - Training Course - Online Event, 25/11/2020-26/11/2020 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 5 European CME credits (ECMEC®s). Each Medical specialist should claim only those hours of credits that he/she actually spent in the educational activity.

Become a member

This course is organised by the ESC Working Group on Cardiovascular Pharmacotherapy.
Not a member yet? Join today

Who should attend

This course is dedicated to physicians dealing with hospital admissions, ward and outpatient consultations.

Previous courses

The first course on Pharmacotherapy in Older People took place in October 2019 in London, with over 40 participants.

Access the resources


For any questions, please contact us on